4.4 Article

Nonproteinuric Diabetic Nephropathy When Diabetics Don't Read the Textbook

Journal

MEDICAL CLINICS OF NORTH AMERICA
Volume 97, Issue 1, Pages 53-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2012.10.006

Keywords

Diabetic nephropathy; Nonproteinuric; Normoalbuminuria

Funding

  1. Keryx Biopharmaceuticals, Inc
  2. Chemocentryx, Inc
  3. Eli Lilly, Inc
  4. Nephrogenex, Inc
  5. Hypertension, and Nephrology Clinical Trials Center
  6. Vanderbilt University Medical Center [MCN 5-3223]
  7. Nashville, USA [TN 37232]

Ask authors/readers for more resources

Diabetic nephropathy (DN) refers to the structural and functional changes in the kidneys of patients with diabetes mellitus (type 1 or 2). A subset of patients with presumed DN may not have overt proteinuria as a prerequisite to renal failure, contrary to the classical paradigm. No animal model fully recapitulates the human subset. All studies on this subject are observational and most lack biopsy data. Many mechanisms have been postulated, including use of renin-angiotensin system agents, recurrent bouts of acute kidney injury, genetic predisposition, and renal lesions other than DN. A well-designed biopsy study and a series of intervention trials are needed to fully understand this entity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available